Brief: Oramed Announces $50 Million Registered Direct Offering Of Common Stock Priced At-The-Market Under Nasdaq Rules
03/11/2021 16:52
Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING OF
COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nPn2TjBcta
Further company coverage: ORMP.O
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results